NYSEAMERICAN : CPHI
China Pharma Holdings, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · China
Last price 0.6206 USD (Oct 30, 2026, 9:21 AM EDT) · Market cap 26.70M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
China Pharma Holdings, Inc. (CPHI) reported revenue of 3.91M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 3.91M | 4.14M | 4.53M | 7.01M | 8.10M | 9.64M |
| Cost of Revenue | 3.45M | 4.28M | 6.51M | 7.29M | 8.60M | 9.29M |
| Gross Profit | 460.17K | -131.95K | -1.99M | -281.08K | -493.92K | 349.27K |
| Selling, General & Admin | 4.50M | 2.83M | 2.31M | 2.25M | 2.96M | 3.15M |
| Research & Development | 332.39K | 129.34K | 283.94K | 240.08K | 185.86K | 318.96K |
| Operating Expenses | 4.84M | 2.96M | 2.60M | 2.47M | 3.06M | 3.21M |
| Operating Income | -4.38M | -3.09M | -4.59M | -2.75M | -3.55M | -2.86M |
| Interest Expense | -99.04K | -102.04K | -154.14K | -333.60K | -434.62K | -542.00K |
| Interest & Investment Income | 735.00 | 2.00K | 6.64K | 6.60K | 10.76K | 3.04K |
| EBT Excluding Unusual Items | -4.47M | -3.19M | -4.74M | -3.08M | -3.97M | -3.40M |
| Pretax Income | -4.47M | -3.19M | -4.74M | -3.08M | -3.97M | -3.40M |
| Net Income | -4.47M | -3.19M | -4.74M | -3.08M | -3.97M | -3.40M |
| Net Income to Common | -4.47M | -3.19M | -4.74M | -3.08M | -3.97M | -3.40M |
| Shares Outstanding (Basic) | 19.70M | 4.29M | 1.75M | 338.36K | 105.14K | 92.26K |
| Shares Outstanding (Diluted) | 19.70M | 4.29M | 1.75M | 338.36K | 105.14K | 92.26K |
| EPS (Basic) | -0.23 | -0.74 | -2.71 | -9.10 | -37.79 | -36.85 |
| EPS (Diluted) | -0.23 | -0.74 | -2.71 | -9.10 | -37.79 | -36.85 |
| Free Cash Flow | -141.56K | 88.94K | -444.47K | -711.20K | -811.51K | -687.89K |
| Free Cash Flow Per Share | -0.01 | 0.02 | -0.26 | -2.10 | -7.72 | -7.46 |
| Gross Margin | 11.76% | -3.18% | -43.84% | -4.01% | -6.09% | 3.62% |
| Operating Margin | -111.82% | -74.50% | -101.32% | -39.25% | -43.79% | -29.67% |
| Profit Margin | -114.33% | -76.92% | -104.58% | -43.91% | -49.02% | -35.26% |
| Free Cash Flow Margin | -3.62% | 2.15% | -9.81% | -10.14% | -10.01% | -7.13% |
| EBITDA | -1.44M | -1.58M | -1.97M | 1.83K | -848.44K | 227.31K |
| EBITDA Margin | -36.81% | -38.22% | -43.52% | 0.03% | -10.47% | 2.36% |
| D&A For EBITDA | 2.94M | 1.50M | 2.62M | 2.75M | 2.70M | 3.09M |
| EBIT | -4.38M | -3.09M | -4.59M | -2.75M | -3.55M | -2.86M |
| EBIT Margin | -111.82% | -74.50% | -101.32% | -39.25% | -43.79% | -29.67% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 304.87K | 345.11K | 626.88K | 1.42M | 2.03M | 4.86M |
| Cash & Short-Term Investments | 304.87K | 345.11K | 626.88K | 1.42M | 2.03M | 4.86M |
| Accounts Receivable | 181.62K | 241.41K | 232.14K | 504.45K | 421.53K | 714.48K |
| Other Receivables | 66.63K | 49.26K | 30.29K | 157.94K | 29.14K | 29.56K |
| Receivables | 248.25K | 290.67K | 262.43K | 662.39K | 450.67K | 744.04K |
| Inventory | 1.36M | 1.63M | 2.28M | 3.73M | 3.39M | 3.34M |
| Prepaid Expenses | 86.97K | 82.37K | 81.33K | 110.26K | 77.70K | 58.79K |
| Other Current Assets | 1.82K | 18.64K | 65.92K | 13.78K | 91.36K | |
| Total Current Assets | 2.01M | 2.35M | 3.27M | 6.00M | 5.96M | 9.09M |
| Property, Plant & Equipment | 4.37M | 4.57M | 4.92M | 7.22M | 10.01M | 13.41M |
| Other Intangible Assets | 38.34M | 24.08M | 6.70M | 3.26M | 1.81M | 147.84K |
| Total Assets | 44.71M | 31.00M | 14.89M | 16.47M | 17.78M | 22.65M |
| Accounts Payable | 734.04K | 891.08K | 225.11K | 966.42K | 667.08K | 926.75K |
| Accrued Expenses | 2.81M | 2.62M | 2.28M | 2.58M | 2.42M | 1.86M |
| Short-Term Debt | 1.95M | 1.73M | 1.30M | 1.13M | 2.48M | 2.78M |
| Current Portion of Long-Term Debt | 1.96M | 1.98M | 1.02M | 1.97M | 6.24M | 4.33M |
| Current Portion of Leases | 73.07K | 71.63K | 39.32K | 77.73K | 40.45K | 85.28K |
| Current Unearned Revenue | 153.64K | 111.58K | 162.21K | 90.51K | 520.29K | 210.03K |
| Other Current Liabilities | 372.58K | 327.03K | ||||
| Total Current Liabilities | 7.68M | 7.40M | 5.02M | 6.82M | 12.74M | 10.51M |
| Long-Term Debt | 1.39M | 1.41M | 5.25M | |||
| Long-Term Leases | 75.29K | 111.55K | 39.91K | 44.18K | ||
| Long-Term Deferred Tax Liabilities | 771.73K | 747.80K | 731.20K | 742.11K | 754.70K | 824.41K |
| Total Liabilities | 8.53M | 8.26M | 7.14M | 9.01M | 13.49M | 16.63M |
| Common Stock | 40.52K | 15.52K | 3.26K | 10.62K | 1.50K | 47.34K |
| Additional Paid-In Capital | 73.50M | 58.54M | 40.63M | 35.28M | 28.93M | 25.65M |
| Retained Earnings | -49.82M | -47.21M | -44.03M | -39.29M | -36.21M | -32.24M |
| Comprehensive Income & Other | 12.45M | 11.40M | 11.14M | 11.45M | 11.57M | 12.56M |
| Shareholders' Equity | 36.18M | 22.74M | 7.75M | 7.45M | 4.29M | 6.02M |
| Total Liabilities & Equity | 44.71M | 31.00M | 14.89M | 16.47M | 17.78M | 22.65M |
| Total Debt | 4.06M | 3.89M | 3.75M | 4.63M | 8.76M | 12.49M |
| Net Cash (Debt) | -3.75M | -3.54M | -3.12M | -3.21M | -6.73M | -7.63M |
| Net Cash Per Share | -0.19 | -0.83 | -1.79 | -9.49 | -63.99 | -82.69 |
| Filing Date Shares Outstanding | 43.02M | 40.52M | 3.26M | 1.48M | 169.16K | 94.68K |
| Total Common Shares Outstanding | 40.52M | 15.52M | 3.26M | 1.06M | 149.82K | 94.68K |
| Working Capital | -5.67M | -5.05M | -1.75M | -823.73K | -6.77M | -1.42M |
| Book Value Per Share | 0.89 | 1.47 | 2.38 | 7.02 | 28.63 | 63.56 |
| Tangible Book Value | -2.16M | -1.34M | 1.05M | 4.20M | 2.48M | 5.87M |
| Tangible Book Value Per Share | -0.05 | -0.09 | 0.32 | 3.95 | 16.57 | 62.00 |
| Land | 413.55K | 400.73K | 391.84K | 397.68K | 404.43K | 441.78K |
| Buildings | 9.60M | 9.31M | 9.10M | 9.23M | 9.39M | 10.26M |
| Machinery | 29.06M | 28.18M | 27.49M | 27.86M | 28.53M | 30.74M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -4.47M | -3.19M | -4.74M | -3.08M | -3.97M | -3.40M |
| Depreciation & Amortization | 3.05M | 1.58M | 2.68M | 2.75M | 2.70M | 3.09M |
| Other Amortization | 250.00K | |||||
| Loss (Gain) From Sale of Assets | 3.36K | 45.38K | ||||
| Stock-Based Compensation | 78.27K | 15.24K | ||||
| Provision & Write-off of Bad Debts | -13.67M | -13.67M | 5.70K | -15.76K | -93.85K | -255.22K |
| Other Operating Activities | 132.27K | 552.69K | 452.94K | -7.97K | ||
| Change in Accounts Receivable | 13.23M | 13.21M | -197.71K | -938.02K | -170.19K | -545.53K |
| Change in Inventory | 791.77K | 598.10K | 1.59M | 420.37K | 229.15K | 1.01M |
| Change in Accounts Payable | 163.36K | 650.31K | -733.92K | 312.05K | -187.73K | -332.78K |
| Change in Unearned Revenue | 69.49K | -53.44K | 73.72K | -423.26K | 339.66K | -520.41K |
| Change in Other Net Operating Assets | 559.40K | 466.55K | 458.78K | 232.69K | 667.47K | 436.81K |
| Operating Cash Flow | -140.49K | 148.26K | -406.06K | -699.69K | -409.55K | -249.84K |
| Capital Expenditures | -1.06K | -59.32K | -38.41K | -11.52K | -401.96K | -438.06K |
| Sale (Purchase) of Intangibles | -77.93K | -77.93K | -253.31K | |||
| Investing Cash Flow | -78.99K | -137.25K | -291.72K | -11.52K | -401.96K | -438.06K |
| Short-Term Debt Issued | 261.07K | 27.35K | 30.57K | 28.96K | 1.18M | |
| Long-Term Debt Issued | 700.00K | 492.76K | 1.53M | 564.97K | 8.83M | |
| Total Debt Issued | 130.86K | 961.07K | 520.11K | 1.56M | 593.93K | 10.01M |
| Short-Term Debt Repaid | -223.01K | -562.66K | ||||
| Long-Term Debt Repaid | -1.26M | -553.90K | -1.49M | -2.14M | -4.85M | |
| Total Debt Repaid | -284.87K | -1.26M | -553.90K | -1.49M | -2.36M | -5.41M |
| Net Debt Issued (Repaid) | -154.01K | -294.03K | -33.78K | 73.14K | -1.77M | 4.60M |
| Financing Cash Flow | -154.01K | -294.03K | -33.78K | 73.14K | -1.77M | 4.60M |
| Foreign Exchange Rate Adjustments | 53.34K | 1.25K | -65.40K | 31.93K | -247.57K | -8.44K |
| Net Cash Flow | -320.16K | -281.77K | -796.96K | -606.13K | -2.83M | 3.90M |
| Free Cash Flow | -141.56K | 88.94K | -444.47K | -711.20K | -811.51K | -687.89K |
| Free Cash Flow Margin | -3.62% | 2.15% | -9.81% | -10.14% | -10.01% | -7.13% |
| Free Cash Flow Per Share | -0.01 | 0.02 | -0.26 | -2.10 | -7.72 | -7.46 |
| Levered Free Cash Flow | 1.11M | 1.05M | 375.08K | -168.57K | 849.72K | -642.16K |
| Unlevered Free Cash Flow | 1.17M | 1.12M | 471.42K | 39.93K | 1.12M | -553.41K |
| Cash Interest Paid | 64.54K | 74.77K | 86.77K | 92.44K | 141.80K | 218.23K |
| Change in Working Capital | 14.81M | 14.87M | 1.19M | -396.18K | 878.34K | 51.79K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 27.32M | 6.08M | 4.48M | 3.99M | 4.95M | 22.85M |
| Enterprise Value | 31.07M | 9.38M | 7.77M | 8.01M | 12.98M | 29.92M |
| Last Close Price | 0.62 | 1.21 | 2.33 | 6.05 | 47.95 | 241.30 |
| PS Ratio | 6.87 | 1.47 | 0.99 | 0.57 | 0.61 | 2.37 |
| PB Ratio | 0.70 | 0.27 | 0.58 | 0.54 | 1.15 | 3.80 |
| P/TBV Ratio | 4.25 | 0.95 | 2.00 | 3.89 | ||
| P/FCF Ratio | 68.33 | |||||
| P/OCF Ratio | 40.99 | |||||
| EV/Sales Ratio | 7.83 | 2.26 | 1.72 | 1.14 | 1.60 | 3.10 |
| EV/EBITDA Ratio | 4,370.46 | 131.65 | ||||
| EV/FCF Ratio | 105.43 | |||||
| Debt / Equity Ratio | 0.11 | 0.17 | 0.48 | 0.62 | 2.04 | 2.08 |
| Debt / EBITDA Ratio | 58.59 | 39.10 | ||||
| Debt / FCF Ratio | 43.71 | |||||
| Net Debt / Equity Ratio | 0.10 | 0.16 | 0.40 | 0.43 | 1.57 | 1.27 |
| Net Debt / EBITDA Ratio | -2.60 | -2.24 | -1.58 | 1,751.33 | -7.93 | 33.56 |
| Net Debt / FCF Ratio | -26.50 | 39.83 | -7.02 | -4.51 | -8.29 | -11.09 |
| Asset Turnover | 0.13 | 0.18 | 0.29 | 0.41 | 0.40 | 0.44 |
| Inventory Turnover | 2.27 | 2.19 | 2.17 | 2.05 | 2.55 | 2.64 |
| Quick Ratio | 0.07 | 0.09 | 0.18 | 0.31 | 0.20 | 0.53 |
| Current Ratio | 0.26 | 0.32 | 0.65 | 0.88 | 0.47 | 0.86 |
| Return on Equity (ROE) | -20.99% | -20.91% | -62.31% | -52.43% | -77.08% | -48.49% |
| Return on Assets (ROA) | -9.35% | -8.41% | -18.29% | -10.04% | -10.97% | -8.17% |
| Return on Capital Employed (ROCE) | -11.80% | -13.10% | -46.50% | -28.50% | -70.40% | -23.60% |
| Earnings Yield | -35.76% | -52.46% | -105.81% | -77.22% | -80.22% | -14.88% |
| FCF Yield | -0.53% | 1.46% | -9.93% | -17.84% | -16.39% | -3.01% |
| Buyback Yield / Dilution | -646.10% | -145.73% | -416.13% | -221.82% | -13.96% | -5.75% |